1 Composite morbidity (as defined by trials) |
10 |
5041 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.57 [0.45, 0.72] |
1.1 Cephalosporin 1 g |
5 |
2144 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.55 [0.35, 0.86] |
1.2 Cephalosporin 2 g |
5 |
2897 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.57 [0.43, 0.76] |
2 Endomyometritis |
10 |
5041 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.54 [0.36, 0.79] |
2.1 Cephalosporin 1 g |
5 |
2144 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.58 [0.30, 1.12] |
2.2 Cephalosporin 2 g |
5 |
2897 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.51 [0.32, 0.83] |
3 Wound infection |
10 |
5041 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.59 [0.44, 0.81] |
3.1 Cephalosporin 1 g |
5 |
2144 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.55 [0.30, 1.01] |
3.2 Cephalosporin 2 g |
5 |
2897 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.61 [0.43, 0.88] |
4 UTI/cystitis/pyelonephritis |
8 |
4001 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.02 [0.65, 1.59] |
5 Pelvic abscess |
1 |
741 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.00 [0.06, 15.97] |
6 Respiratory infection (pneumonia) |
4 |
1849 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.30 [0.34, 15.45] |
7 Hospital length of stay (days) |
2 |
1342 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.17 [‐0.30, ‐0.04] |
8 Febrile Illness |
4 |
2650 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.93 [0.63, 1.35] |